These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8373751)

  • 1. Preparation of peptide-carrying microspheres with bioactivity on platelets.
    Kasuya Y; Fujimoto K; Miyamoto M; Juji T; Otaka A; Funakoshi S; Fujii N; Kawaguchi H
    J Biomater Sci Polym Ed; 1993; 4(4):369-80. PubMed ID: 8373751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic tetrapeptide as a novel platelet-preserving agent during cardiopulmonary bypass.
    Tatsumi E; Matsuda T; Takano H; Taenaka Y; Noda H; Kinoshita M; Sekii H; Yagura A; Takaichi S; Akutsu T
    ASAIO Trans; 1988; 34(3):813-6. PubMed ID: 3196604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
    Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
    Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel potent peptidyl platelet preserving agent: molecular design and biologic activity.
    Ozeki E; Matsuda T
    ASAIO Trans; 1990; 36(3):M562-4. PubMed ID: 2252751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
    Moritani Y; Sato K; Shigenaga T; Hisamichi N; Ichihara M; Akamatsu S; Suzuki Ki; Nii T; Kaku S; Kawasaki T; Matsumoto Y; Inagaki O; Tomioka K; Yanagisawa I
    Eur J Pharmacol; 2002 Mar; 439(1-3):43-52. PubMed ID: 11937091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human neutrophils by Arg-Gly-Asp-Ser immobilized on microspheres.
    Kasuya Y; Fujimoto K; Miyamoto M; Kawaguchi H
    J Biomed Mater Res; 1994 Mar; 28(3):397-404. PubMed ID: 8077255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet function.
    van Wyk V; Leblond L; Winocour PD; Devine DV; Gyongyossy-Issa MI
    Thromb Res; 2000 Aug; 99(4):343-52. PubMed ID: 10963785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
    Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function.
    Weiss DJ; Evanson OA; Wells RE
    Am J Vet Res; 1997 May; 58(5):457-60. PubMed ID: 9140550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two different types of nonthrombogenic surfaces: PEG suppresses platelet adhesion ATP-independently but HEMA-St block copolymer requires ATP consumption of platelets to prevent adhesion.
    Uchida K; Yamato M; Ito E; Kwon OH; Kikuchi A; Sakai K; Okano T
    J Biomed Mater Res; 2000 Jun; 50(4):585-90. PubMed ID: 10756317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
    Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M
    Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
    Williams S; Gralnick H
    Thromb Res; 1987 May; 46(3):457-71. PubMed ID: 3037722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
    Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
    Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads.
    Liu Q; Rooney MM; Kasirer-Friede A; Brown E; Lord ST; Frojmovic MM
    Biochim Biophys Acta; 1998 Jun; 1385(1):33-42. PubMed ID: 9630497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the structure of support microspheres on leucocyte activation by RGDS-carrying microspheres.
    Kasuya Y; Fujimoto K; Kawaguchi H; Miyamoto M
    Biomaterials; 1994 Jun; 15(8):570-6. PubMed ID: 7948575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
    Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
    Foster MR; Hornby EJ; Brown S; Hann M; Kitchin J; Pike N; Ward P
    Thromb Res; 1994 Aug; 75(3):269-84. PubMed ID: 7992238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl antithrombogenic agents for extracorporeal blood circulation.
    Ito S; Matsuda T; Takemoto Y; Yamamoto K; Kishimoto T; Maekawa M
    Int J Artif Organs; 1992 Dec; 15(12):737-45. PubMed ID: 1493949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of fibrinogen and platelet membrane glycoprotein IIb/IIIa in shear-induced platelet aggregation.
    Ikeda Y; Murata M; Araki Y; Watanabe K; Ando Y; Itagaki I; Mori Y; Ichitani M; Sakai K
    Thromb Res; 1988 Jul; 51(2):157-63. PubMed ID: 3187957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.